CIK 0001109354
- Large accelerated filer
BRUKER CORP
Sign in to watch- Ticker
- BRKR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043110160
- Phone
- +1 978-663-3660
- Business address
- 40 MANNING RD, BILLERICA, MA, 01821
- Former names
- BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
Securities
- BRKR Common Stock Nasdaq
- BRKRP 6.375% Mandatory Convertible Preferred Stock, Series A Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $105,740
- in 1 filing
Net −$105,740. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-05 | ORNELL JOHN A Director | Grant or award | +4,577 | 4,577 | ||
| 2017-01-05 | Requardt Hermann Fritz Director | Grant or award | +4,577 | 4,577 | ||
| 2017-01-05 | ROSENTHAL BOB Director | Grant or award | +4,577 | 4,577 | ||
| 2017-01-05 | PACKER RICHARD A Director | Grant or award | +4,577 | 33,684.02 | ||
| 2016-12-15 | LAUKIEN FRANK H CEO, President | Purchase | +4,725 | $21.22 | $100K | 37,704,331 |
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise | +5,000 | $12.96 | $65K | 5,000 |
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise | +5,000 | $12.06 | $60K | 10,000 |
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise | +10,000 | $16.42 | $164K | 20,000 |
| 2016-12-13 | VAN INGEN CHRIS Director | Sale | −20,000 | $22.29 | $446K | 0 |
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise · Stock Option (Right to buy) | −5,000 | 0 | ||
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2016-12-13 | VAN INGEN CHRIS Director | Option exercise · Stock Option (Right to buy) | −10,000 | 0 | ||
| 2016-11-25 | LAUKIEN FRANK H CEO, President | Purchase | +2,124 | $22.90 | $49K | 37,699,606 |
| 2016-10-04 | LAUKIEN FRANK H CEO, President | Grant or award | +48,445 | 37,697,482 | ||
| 2016-10-04 | LAUKIEN FRANK H CEO, President | Grant or award · Stock Option (Right to Buy) | +154,284 | 154,284 | ||
| 2016-10-04 | Munch Mark Exec VP&Pres Bruker Nano Inc. | Grant or award | +18,477 | 63,141 | ||
| 2016-10-04 | Munch Mark Exec VP&Pres Bruker Nano Inc. | Grant or award · Stock Option (Right to Buy) | +58,843 | 58,843 | ||
| 2016-10-04 | Srega Juergen Group President Bruker CALID | Grant or award | +12,393 | 69,106 | ||
| 2016-10-04 | Srega Juergen Group President Bruker CALID | Grant or award · Stock Option (Right to Buy) | +39,468 | 39,468 | ||
| 2016-10-04 | Lenggenhager Rene President, BioSpin Group | Grant or award | +5,634 | 11,037 |
Page 30 of 39 · 771 trades